Carcinoid heart disease

Heidi M. Connolly, Patricia Pellikka

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Progress in the medical and surgical management of patients with carcinoid disease has resulted in improved symptoms and survival. Carcinoid heart disease remains a major cause of morbidity and mortality among patients with malignant carcinoid syndrome. Limited medical treatment options are available for patients with symptomatic carcinoid heart disease. At the Mayo Clinic (Rochester, MN), we have taken an aggressive approach to severe valvular dysfunction from carcinoid heart disease. Patients with severe carcinoid heart disease currently are referred for cardiac operation when they develop cardiac symptoms, ventricular dysfunction, or (rarely) in anticipation of hepatic surgery. Surgical outcome depends on patient age and functional class at the time of cardiac surgery. Despite metastatic disease that limits longevity, cardiac surgical survivors usually demonstrate dramatic improvement in functional capacity. Cardiac surgery should be considered early for patients with symptomatic carcinoid heart disease and controlled carcinoid symptoms. An experienced medical, surgical, and anesthetic team approach to the patient with carcinoid heart disease is critical in order to provide state of the art management.

Original languageEnglish (US)
Pages (from-to)96-101
Number of pages6
JournalCurrent Cardiology Reports
Volume8
Issue number2
DOIs
StatePublished - Mar 2006

Fingerprint

Carcinoid Heart Disease
Carcinoid Tumor
Thoracic Surgery
Malignant Carcinoid Syndrome
Ventricular Dysfunction
Survivors
Anesthetics
Morbidity
Survival
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Carcinoid heart disease. / Connolly, Heidi M.; Pellikka, Patricia.

In: Current Cardiology Reports, Vol. 8, No. 2, 03.2006, p. 96-101.

Research output: Contribution to journalReview article

Connolly, Heidi M. ; Pellikka, Patricia. / Carcinoid heart disease. In: Current Cardiology Reports. 2006 ; Vol. 8, No. 2. pp. 96-101.
@article{ac2f8ccf9c30475185aecc6970f6735a,
title = "Carcinoid heart disease",
abstract = "Progress in the medical and surgical management of patients with carcinoid disease has resulted in improved symptoms and survival. Carcinoid heart disease remains a major cause of morbidity and mortality among patients with malignant carcinoid syndrome. Limited medical treatment options are available for patients with symptomatic carcinoid heart disease. At the Mayo Clinic (Rochester, MN), we have taken an aggressive approach to severe valvular dysfunction from carcinoid heart disease. Patients with severe carcinoid heart disease currently are referred for cardiac operation when they develop cardiac symptoms, ventricular dysfunction, or (rarely) in anticipation of hepatic surgery. Surgical outcome depends on patient age and functional class at the time of cardiac surgery. Despite metastatic disease that limits longevity, cardiac surgical survivors usually demonstrate dramatic improvement in functional capacity. Cardiac surgery should be considered early for patients with symptomatic carcinoid heart disease and controlled carcinoid symptoms. An experienced medical, surgical, and anesthetic team approach to the patient with carcinoid heart disease is critical in order to provide state of the art management.",
author = "Connolly, {Heidi M.} and Patricia Pellikka",
year = "2006",
month = "3",
doi = "10.1007/s11886-006-0019-9",
language = "English (US)",
volume = "8",
pages = "96--101",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "2",

}

TY - JOUR

T1 - Carcinoid heart disease

AU - Connolly, Heidi M.

AU - Pellikka, Patricia

PY - 2006/3

Y1 - 2006/3

N2 - Progress in the medical and surgical management of patients with carcinoid disease has resulted in improved symptoms and survival. Carcinoid heart disease remains a major cause of morbidity and mortality among patients with malignant carcinoid syndrome. Limited medical treatment options are available for patients with symptomatic carcinoid heart disease. At the Mayo Clinic (Rochester, MN), we have taken an aggressive approach to severe valvular dysfunction from carcinoid heart disease. Patients with severe carcinoid heart disease currently are referred for cardiac operation when they develop cardiac symptoms, ventricular dysfunction, or (rarely) in anticipation of hepatic surgery. Surgical outcome depends on patient age and functional class at the time of cardiac surgery. Despite metastatic disease that limits longevity, cardiac surgical survivors usually demonstrate dramatic improvement in functional capacity. Cardiac surgery should be considered early for patients with symptomatic carcinoid heart disease and controlled carcinoid symptoms. An experienced medical, surgical, and anesthetic team approach to the patient with carcinoid heart disease is critical in order to provide state of the art management.

AB - Progress in the medical and surgical management of patients with carcinoid disease has resulted in improved symptoms and survival. Carcinoid heart disease remains a major cause of morbidity and mortality among patients with malignant carcinoid syndrome. Limited medical treatment options are available for patients with symptomatic carcinoid heart disease. At the Mayo Clinic (Rochester, MN), we have taken an aggressive approach to severe valvular dysfunction from carcinoid heart disease. Patients with severe carcinoid heart disease currently are referred for cardiac operation when they develop cardiac symptoms, ventricular dysfunction, or (rarely) in anticipation of hepatic surgery. Surgical outcome depends on patient age and functional class at the time of cardiac surgery. Despite metastatic disease that limits longevity, cardiac surgical survivors usually demonstrate dramatic improvement in functional capacity. Cardiac surgery should be considered early for patients with symptomatic carcinoid heart disease and controlled carcinoid symptoms. An experienced medical, surgical, and anesthetic team approach to the patient with carcinoid heart disease is critical in order to provide state of the art management.

UR - http://www.scopus.com/inward/record.url?scp=33645295505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645295505&partnerID=8YFLogxK

U2 - 10.1007/s11886-006-0019-9

DO - 10.1007/s11886-006-0019-9

M3 - Review article

C2 - 16524535

AN - SCOPUS:33645295505

VL - 8

SP - 96

EP - 101

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 2

ER -